Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries

• Main Authors: Dallas J. Smith (Author), Huichang Bi (Author), Josias Hamman (Author), Xiaochao Ma (Author), Constance Mitchell (Author), Kumbukani Nyirenda (Author), Tsitsi Monera-Penduka (Author), Hellen Oketch-Rabah (Author), Mary F. Paine (Author), Syril Pettit (Author), Wihan Pheiffer (Author), Richard B. Van Breemen (Author), Michelle Embry (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The COVID-19 pandemic sparked the development of novel anti-viral drugs that have shown to be effective in reducing both fatality and hospitalization rates in patients with elevated risk for COVID-19 related morbidity or mortality. Currently, nirmatrelvir/ritonavir (Paxlovid™) fixed-dose combination...